• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION(RIDGEFIELD) SYNVISC ONE MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION(RIDGEFIELD) SYNVISC ONE MOZ Back to Search Results
Lot Number 7RSL021
Device Problem Microbial Contamination of Device (2303)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 01/01/2020
Event Type  Injury  
Event Description
Hypersensitivity reaction [hypersensitivity reaction] ([device malfunction]). Case narrative: the case is linked to: (b)(4) (multiple devices for same patient). Initial information received from united states on 15-jun-2020 and 18-jun-2020 regarding an unsolicited valid serious malfunction case received from other health professional. This case involves a (b)(6) female patient who had hypersensitivity reaction, after treatment with medical device hylan g-f 20, sodium hyaluronate (synvisc one). A device malfunction was identified for the reported lot number. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. After the treatment with hylan g-f 20, sodium hyaluronate in (b)(6) 2017, patient planned on getting the treatment again and ordered the product from pharmacy which was sent directly to her. She changed her mind and did not receive it at that time. Then in (b)(6) 2020 she decided that since she had already paid for it she might as well get it injected. In (b)(6) 2020 (6 weeks before (b)(6) 2020), the patient had treatment with hylan g-f 20, sodium hyaluronate at the dose of 48 mg, once via unknown route (lot - 7rsl021, expiration date: 31-may-2020) for oa (osteoarthritis) in the knee (unclarified which knee) by the healthcare professional. On an unknown date in 2020, after unknown latency, patient had hypersensitivity reaction. Event was assessed as medically significant. When patient realized that she had received a injection of the recalled lot, she felt that was the reason for the reason and was now threatening legal action toward her healthcare professional. Action taken: not applicable. It was not reported if the patient received a corrective treatment. Outcome: unknown. A product technical complaint (ptc) was initiated on 16-jun-2020 for synvisc one with lot number: 7rsl021 and global ptc number: (b)(4). Investigation was initiated for increase number of reported aes (adverse events). An investigation was initiated as a result of an unexpected increase in the number of labeled adverse events received from the us market for synvisc one lot 7rsl021. The product met all release testing at time of manufacture in june 2017. Retain samples were retested due to the unexpected increase in adverse events. Higher than expected endotoxin results were obtained. In addition, the presence of microbial contamination was also confirmed. An investigation ((b)(4)) was performed and capas were identified with timelines for implementation of these capas. Investigation complete date: 18-jun-2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNVISC ONE
Type of DeviceMOZ
Manufacturer (Section D)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer (Section G)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key10185098
MDR Text Key201160319
Report Number2246315-2020-00073
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Recall
Type of Report Initial
Report Date 06/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Expiration Date05/31/2020
Device Lot Number7RSL021
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 06/23/2020 Patient Sequence Number: 1
-
-